# The PEERLESS Study

Study · id `cardio:ct-nct05111613` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05111613](<https://clinicaltrials.gov/study/NCT05111613>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05111613

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 692 participants.

## Technical summary

Registry record NCT05111613. Randomized; no masking; primary purpose treatment. Start 2022-02-14 (actual); primary completion 2024-03-01 (actual). Results posted on 2025-11-13.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 692 participants (enrolled count; ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Started: 2022-02-14 (actual) (ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Primary completion: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Completion: 2024-04-11 (actual) (ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Results first posted: 2025-11-13 (ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Countries: United States; Germany; Switzerland (ClinicalTrials.gov record NCT05111613, source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05111613-2025-11-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: The PEERLESS Study
- Acronym: PEERLESS
- Condition: Pulmonary Embolism
- Condition: Pulmonary Thromboembolism
- Intervention (Device): Catheter-Directed Thrombolysis
- Intervention (Device): FlowTriever System
- Lead sponsor: Inari Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as the lead sponsor: Inari Medical (`cardio:org-inari-medical`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis in the Management of Intermediate-Risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial (`cardio:pubmed-39470698`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Evaluation of Catheter-Directed Thrombolysis Device Type and Dosing on Treatment Outcomes in Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis (`cardio:pubmed-41072848`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: ab8c6c38c34a9a37054f50eabaab5817f4c2c7854d80011cae72adc170a35c36
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
